Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nkarta and other ETFs, options, and stocks.
Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells.
Paul J. Hastings
South San Francisco, California
52 Week high
52 Week low
— per share
-$0.79 per share